Kedrion

Developer of plasma-derived products for hemophilia and immune system deficiencies

placeBarga, Tuscany, Italy calendar_todayFounded 2001 groups5,000 employees language kedrion.com

Registered entities

Innovation

13 patent families (9 granted) — focus: Chemistry & metallurgy, Human necessities, Operations & transport; filing pace steady. Cited 264 times.

YearFilings
20124
20137
20144
20154
20163
20172
20183
20193
20211
20231
20241
20251

Social engagement

Social engagement: 98.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include CDP Equity; 4 have since exited.

Investor typeCountShare
Venture capital117%
Private equity583%

Recent activity

15 Jun 2026
Milestone
anniversary
Coming soon